Company Profile
Sientra Stock Price, News & Analysis
- Ticker:
- SIEN
- Exchange:
- NASDAQ
- Sector:
- MedTech
- Location:
- United States
Why the stock is moving
Current closing-price context is not available for SIEN.
Company overview
Business overview
Sientra was a medical aesthetics company focused on breast implants and related surgical products before being acquired. Its story was rooted in device and procedure demand rather than drug development.
Geographic Base and Sector Classification
Sientra was headquartered in the United States and traded on NASDAQ before the acquisition. It sat in medical devices and aesthetics.
Business Model Characteristics
The business depended on product sales, surgeon adoption, and procedure volume in aesthetic surgery. Investors historically watched commercialization, litigation or regulatory issues, and margin trends.
Position Within the Biotechnology Landscape
Sientra was a medtech and aesthetics name, not a biotech developer. Because it has been acquired, it now belongs to the historical healthcare M&A set.
Future catalysts
Sientra’s catalysts are breast-implant and reconstructive-surgery demand, along with operating execution. The company moves on procedural demand and commercial stability.
Recent news
- 01
- 02
- 03
- 04
Sientra to Present at the Stifel 2023 Healthcare Conference
Source: Sientra
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does Sientra do?
Sientra was a medical aesthetics company focused on breast implants and related surgical products before being acquired. Its story was rooted in device and procedure demand rather than drug development.
On which exchange is SIEN stock listed?
Sientra (SIEN) is associated with NASDAQ, United States, MedTech.
What is Sientra?
Sientra’s catalysts are breast-implant and reconstructive-surgery demand, along with operating execution.
Which conditions is Sientra targeting with Sientra?
Sientra’s catalysts are breast-implant and reconstructive-surgery demand, along with operating execution.
How does Sientra describe recent progress with Sientra?
Sientra’s catalysts are breast-implant and reconstructive-surgery demand, along with operating execution.
What future catalysts are investors watching for Sientra?
Sientra’s catalysts are breast-implant and reconstructive-surgery demand, along with operating execution. The company moves on procedural demand and commercial stability.